![Creation of piroxicam nanoform](assets/cache/images/6669%281%29-400x400-1dc.jpg)
The first clinical trial of Nanoform Piroxicam manuractured by the Finnish company will begin at the end of 2020.
![Paroxetine may have anti-cancer effects](assets/cache/images/569-400x400-f01.jpg)
Scientists from Sweden Karolinska Institute have found that a common and often prescribed antidepressant can stop the growth of a malignant tumor.
![Staphylococcus aureus may be a cure](assets/cache/images/mirovye-novosti/mirovye-novosti-2/45896-400x400-40c.jpg)
Scientists have discovered a bacterial toxin that promotes tissue healing.
![Osteoporosis. ACR novelties within the framework of the rheumatology school](assets/cache/images/other-news/en-news/zoleum-box-400x400-681.jpg)
The company "Ananta Medicare" supported the holding of the rheumatology school and took part in it. More than 1,500 doctors have got acquainted with the materials of the school remotely.
![Antibiotics can treat dementia](assets/cache/images/56-400x400-fda.jpg)
Scientists from the United States have found that a certain class of antibiotics could be promising for the treatment of frontotemporal dementia.
![New toxoplasmosis vaccine](assets/cache/images/other-news/en-news/49496-400x400-1b8.jpg)
By using a new approach, scientists have developed an experimental vaccine against Toxoplasma gondii.
![A two-vaccine regimen may provide the best protection against Ebola virus](assets/cache/images/mirovye-novosti/mirovye-novosti-2/48487-400x400-98d.jpg)
A study has shown that sequential administration of two different Ebola virus vaccines at regular intervals may provide the best immune response.
![EMA may approve new gene therapy product by Bluebird Bio Company](assets/cache/images/56356-400x400-5a5.jpg)
European Medicines Agency is considering the application of the American Bluebird Bio for the registration of cerebral adrenoleukodystrophy drug.